AGÕæÈ˹ٷ½

STOCK TITAN

MariMed Announces First Quarter 2025 Earnings Date

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

MariMed (CSE: MRMD, OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, has scheduled its first quarter 2025 earnings release for May 7, 2025 after market close.

The company will host a conference call to discuss the financial results on May 8, 2025 at 8:00 a.m. EDT. Investors can access the webcast through MariMed's Investor Relations website, where a playback will also be available after the call.

MariMed (CSE: MRMD, OTCQX: MRMD), un'azienda leader nel settore dei beni di consumo a base di cannabis e nel commercio al dettaglio, ha programmato la pubblicazione dei risultati finanziari del primo trimestre 2025 per il 7 maggio 2025 dopo la chiusura del mercato.

L'azienda ospiterà una conferenza telefonica per discutere i risultati finanziari l'8 maggio 2025 alle 8:00 EDT. Gli investitori possono accedere al webcast tramite il sito web delle Relazioni con gli Investitori di MariMed, dove sarà disponibile anche una registrazione dopo la chiamata.

MariMed (CSE: MRMD, OTCQX: MRMD), una empresa líder en productos de consumo empaquetados de cannabis y minorista, ha programado la publicación de resultados del primer trimestre de 2025 para el 7 de mayo de 2025 después del cierre del mercado.

La empresa llevará a cabo una conferencia telefónica para discutir los resultados financieros el 8 de mayo de 2025 a las 8:00 a.m. EDT. Los inversores pueden acceder a la transmisión web a través del sitio web de Relaciones con Inversores de MariMed, donde también estará disponible una grabación después de la llamada.

마리메드 (CSE: MRMD, OTCQX: MRMD), ì„ ë„ì ì¸ 대마초 소비ìž� 회사ì´ìž 소매업체가 2025ë…� 5ì›� 7ì� 시장 ë§ˆê° í›� ì²� 분기 ì‹¤ì  ë°œí‘œë¥� 예정했습니다.

ÐëŒì‚¬µç� 2025ë…� 5ì›� 8ì� 오전 8ì‹� EDTì—� 재무 ê²°ê³¼ë¥� ë…¼ì˜í•˜ê¸° 위해 컨í¼ëŸ°ìФ ì½œì„ ê°œìµœí•©ë‹ˆë‹�. 투ìžìžë“¤ì€ 마리메드ì� 투ìžìž� ê´€ê³� 웹사ì´íЏë¥� 통해 웹ìºìŠ¤íŠ¸ì—� ì ‘ì†í•� ìˆ� 있으ë©�, 통화 후ì—ëŠ� 재ìƒë� 가능합니다.

MariMed (CSE: MRMD, OTCQX: MRMD), une entreprise leader dans le domaine des produits de consommation à base de cannabis et de la vente au détail, a prévu la publication de ses résultats financiers pour le premier trimestre 2025 pour le 7 mai 2025 après la fermeture du marché.

L'entreprise organisera une conférence téléphonique pour discuter des résultats financiers le 8 mai 2025 à 8h00 EDT. Les investisseurs peuvent accéder au webinaire via le site des Relations avec les Investisseurs de MariMed, où une rediffusion sera également disponible après l'appel.

MariMed (CSE: MRMD, OTCQX: MRMD), ein führendes Unternehmen für Cannabis-Verbrauchsgüter und Einzelhandel, hat die Veröffentlichung seiner Ergebnisse für das erste Quartal 2025 für den 7. Mai 2025 nach Marktschluss angesetzt.

Das Unternehmen wird am 8. Mai 2025 um 8:00 Uhr EDT eine Telefonkonferenz abhalten, um die finanziellen Ergebnisse zu besprechen. Investoren können über die Website der Investor Relations von MariMed auf das Webcast zugreifen, wo auch eine Wiedergabe nach dem Anruf verfügbar sein wird.

Positive
  • None.
Negative
  • None.

NORWOOD, Mass., April 08, 2025 (GLOBE NEWSWIRE) -- . (“MariMed� or “Company�) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report first quarter 2025 financial results on May 7, 2025 after the markets close. Management will host a conference call on May 8, 2025 at 8:00 a.m. EDT to discuss financial results.

A webcast will be available and can be accessed via MariMed’s Investor Relations website at . A playback of the call will also be made available on MariMed’s Investor Relations website.

About MariMed
MariMed Inc. is a leading multi-state cannabis operator, known for developing and managing state-of-the-art cultivation, production, and retail facilities. Our award-winning portfolio of cannabis brands, including Betty's Eddies�, Bubby’s Baked�, InHouse�, Nature’s Heritage�, and Vibations�, sets us apart as an industry leader. These trusted brands, crafted with quality and innovation, are recognized and loved by consumers across the country. With a commitment to excellence, MariMed continues to drive growth and set new standards in the cannabis industry. For additional information, visit .

Company Contact:
Howard Schacter
Chief Communications Officer 
Email:
Phone: (781) 277-0007


FAQ

When will MariMed (MRMD) release its Q1 2025 earnings?

MariMed will release Q1 2025 earnings on May 7, 2025, after markets close.

What time is MariMed's (MRMD) Q1 2025 earnings call?

The earnings conference call is scheduled for May 8, 2025, at 8:00 a.m. EDT.

How can investors access MariMed's (MRMD) Q1 2025 earnings call?

Investors can access the webcast through MariMed's Investor Relations website.

Will there be a replay available for MariMed's (MRMD) Q1 2025 earnings call?

Yes, a playback of the call will be made available on MariMed's Investor Relations website.
Marimed

OTC:MRMD

MRMD Rankings

MRMD Latest News

MRMD Stock Data

38.98M
280.32M
14.02%
0.2%
Drug Manufacturers - Specialty & Generic
Healthcare
United States
Norwood